Positive results with Endocine™ and a vaccine candidate against COVID-19
STOCKHOLM, Sept. 23, 2021 /PRNewswire/ — The first preclinical study, where the adjuvant technology Endocine™ has been evaluated with a vaccine candidate against COVID-19, shows positive results. In May 2021, Eurocine Vaccine signed an evaluation agreement with an innovative North…
Comments Off on Positive results with Endocine™ and a vaccine candidate against COVID-19